ProPhase Labs, Inc. (PRPH)

USD 0.24

(0.33%)

Long Term Debt Summary of ProPhase Labs, Inc.

  • ProPhase Labs, Inc.'s latest annual long term debt in 2023 was 10.25 Million USD , up 54.05% from previous year.
  • ProPhase Labs, Inc.'s latest quarterly long term debt in 2024 Q2 was 10.32 Million USD , up 0.33% from previous quarter.
  • ProPhase Labs, Inc. reported annual long term debt of 6.65 Million USD in 2022, down -53.23% from previous year.
  • ProPhase Labs, Inc. reported annual long term debt of 14.23 Million USD in 2021, down -1.08% from previous year.
  • ProPhase Labs, Inc. reported quarterly long term debt of 10.29 Million USD for 2024 Q1, up 0.35% from previous quarter.
  • ProPhase Labs, Inc. reported quarterly long term debt of 15.01 Million USD for 2023 Q2, up 8.76% from previous quarter.

Annual Long Term Debt Chart of ProPhase Labs, Inc. (2023 - 1996)

Historical Annual Long Term Debt of ProPhase Labs, Inc. (2023 - 1996)

Year Long Term Debt Long Term Debt Growth
2023 10.25 Million USD 54.05%
2022 6.65 Million USD -53.23%
2021 14.23 Million USD -1.08%
2020 14.39 Million USD 0.0%
2019 - USD 0.0%
2018 - USD 0.0%
2017 - USD 0.0%
2016 - USD -100.0%
2015 1.46 Million USD 1366.0%
2014 100 Thousand USD -50.0%
2013 200 Thousand USD -33.33%
2012 300 Thousand USD 0.0%
2011 - USD 0.0%
2010 - USD 0.0%
2009 - USD 0.0%
2008 - USD 0.0%
2007 - USD 0.0%
2006 - USD -100.0%
2005 1.03 Million USD -57.97%
2004 2.46 Million USD 0.0%
2003 - USD 0.0%
2002 - USD 0.0%
2001 - USD 0.0%
2000 - USD 0.0%
1999 - USD 0.0%
1998 - USD 0.0%
1997 - USD 0.0%
1996 - USD 0.0%

Peer Long Term Debt Comparison of ProPhase Labs, Inc.

Name Long Term Debt Long Term Debt Difference
Cosmos Health Inc. 3.03 Million USD -237.952%
Safety Shot Inc 304.9 Thousand USD -3264.305%
Bright Green Corporation 201.78 Thousand USD -4983.679%
Embecta Corp. 1.62 Billion USD 99.369%
ANI Pharmaceuticals, Inc. 309.66 Million USD 96.687%
Aquestive Therapeutics, Inc. 91.07 Million USD 88.737%
Collegium Pharmaceutical, Inc. 489.96 Million USD 97.906%
Dynavax Technologies Corporation 252.41 Million USD 95.936%
Esperion Therapeutics, Inc. 501.54 Million USD 97.955%
Intra-Cellular Therapies, Inc. 13.32 Million USD 23.023%
Pacira BioSciences, Inc. 513.79 Million USD 98.003%
PainReform Ltd. 30 Thousand USD -34093.333%
Sunshine Biopharma, Inc. 539.03 Thousand USD -1803.03%
Sunshine Biopharma, Inc. 539.03 Thousand USD -1803.03%
SCYNEXIS, Inc. 12.15 Million USD 15.635%
China SXT Pharmaceuticals, Inc. 117.12 Thousand USD -8657.865%
Journey Medical Corporation 14.62 Million USD 29.845%
Alpha Teknova, Inc. 13.25 Million USD 22.587%
Procaps Group, S.A. 28.41 Million USD 63.893%
Theratechnologies Inc. 51.26 Million USD 79.989%
Harrow Health, Inc. 183.17 Million USD 94.4%
Sonoma Pharmaceuticals, Inc. 87 Thousand USD -11690.805%
Biofrontera Inc. 804 Thousand USD -1175.871%
DURECT Corporation 2.7 Million USD -279.645%
Supernus Pharmaceuticals, Inc. 33.19 Million USD 69.099%
Cronos Group Inc. 1.55 Million USD -557.986%
OptiNose, Inc. 611 Thousand USD -1578.887%
Ironwood Pharmaceuticals, Inc. 498.3 Million USD 97.941%
Kala Pharmaceuticals, Inc. 34.19 Million USD 69.997%
RedHill Biopharma Ltd. 455 Thousand USD -2154.505%
Organogenesis Holdings Inc. 60.74 Million USD 83.113%
Guardion Health Sciences, Inc. - USD -Infinity%
Cumberland Pharmaceuticals Inc. 12.78 Million USD 19.76%
Radius Health, Inc. 339.66 Million USD 96.98%
Universe Pharmaceuticals INC - USD -Infinity%
Phibro Animal Health Corporation 458.28 Million USD 97.762%
Procaps Group S.A. 28.41 Million USD 63.893%
Alvotech 1.02 Billion USD 99.002%
TherapeuticsMD, Inc. 6.53 Million USD -57.042%
Viatris Inc. 16.18 Billion USD 99.937%
Rockwell Medical, Inc. 8.29 Million USD -23.695%
Aytu BioPharma, Inc. 10.87 Million USD 5.691%
SIGA Technologies, Inc. 335.99 Thousand USD -2953.058%
Tilray Brands, Inc. 287.93 Million USD 96.437%
Lifecore Biomedical, Inc. 120.51 Million USD 91.488%
Shineco, Inc. 10.01 Million USD -2.403%
PetIQ, Inc. 437.82 Million USD 97.657%
Regencell Bioscience Holdings Limited - USD -Infinity%
Incannex Healthcare Limited 210 Thousand USD -4784.762%
Neurocrine Biosciences, Inc. 258.3 Million USD 96.029%
Alimera Sciences, Inc. 64.48 Million USD 84.093%
Silver Spike Investment Corp. - USD -Infinity%
Assertio Holdings, Inc. 38.51 Million USD 73.366%
Shuttle Pharmaceuticals Holdings, Inc. 135.08 Thousand USD -7493.512%
Petros Pharmaceuticals, Inc. 6.85 Million USD -49.591%
Clever Leaves Holdings Inc. 720 Thousand USD -1324.722%
Cyclo Therapeutics, Inc. 22.48 Thousand USD -45523.555%
Avadel Pharmaceuticals plc 32.75 Million USD 68.687%
Hempacco Co., Inc. 5.93 Million USD -72.956%
Talphera, Inc. - USD -Infinity%
Alvotech 1.02 Billion USD 99.002%
Eagle Pharmaceuticals, Inc. 56.21 Million USD 81.753%
Lantheus Holdings, Inc. 616.12 Million USD 98.335%
Currenc Group, Inc. 2.5 Million USD -309.179%
Kamada Ltd. 7.43 Million USD -37.913%
Indivior PLC 235.66 Million USD 95.647%
Evoke Pharma, Inc. 5 Million USD -105.16%
Flora Growth Corp. 942 Thousand USD -988.96%
Cyclo Therapeutics, Inc. 22.48 Thousand USD -45523.555%
Evolus, Inc. 120.35 Million USD 91.477%
HUTCHMED (China) Limited 48.18 Million USD 78.713%
Amphastar Pharmaceuticals, Inc. 589.19 Million USD 98.259%
Akanda Corp. 2.49 Million USD -310.787%